Showing results (1461-1470 of 2,287) with videos related to

Sort By:
Pageof 229
HIV Medicine|October 20, 2007
Impact of transmission of drug-resistant HIV on the course of infection and the treatment success. Data from the German HIV-1 Seroconverter StudyG Poggensee, C Kücherer, J Werning, et al.
HIV Medicine|October 20, 2007
Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitorsP Chetchotisakd, S Anunnatsiri, P Mootsikapun, et al.
HIV Medicine|October 20, 2007
Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000-2004F Bonnet, G Chêne, R Thiébaut, et al.
HIV Medicine|October 20, 2007
Impact of GB virus type C infection on mother-to-child HIV transmission in the Women and Infants Transmission Study CohortE Handelsman, I Cheng, B Thompson, et al.
HIV Medicine|August 19, 2008
Appendicitis in HIV-infected patients during the era of highly active antiretroviral therapyN Crum-Cianflone, J Weekes, M Bavaro
HIV Medicine|July 31, 2007
HIV forensics: pitfalls and acceptable standards in the use of phylogenetic analysis as evidence in criminal investigations of HIV transmissionE J Bernard, Y Azad, A M Vandamme, et al.
HIV Medicine|July 31, 2007
Ferritin levels during structured treatment interruption of highly active antiretroviral therapyJ Boom, E Kösters, C Duncombe, et al.
HIV Medicine|November 21, 2008
The associations between age and the development of laboratory abnormalities and treatment discontinuation for reasons other than virological failure in the first year of highly active antiretroviral therapyC A Sabin, C J Smith, V Delpech, et al.
HIV Medicine|February 4, 2009
Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapyS Skinner, A J Adewale, L DeBlock, et al.
HIV Medicine|February 10, 2009
Health care services utilization stratified by virological and immunological markers of HIV: evidence from a universal health care settingE F Druyts, B Yip, V D Lima, et al.
Pageof 229